Talquetamab Regimens Boost Survival in Multiple Myeloma
19/06/2026
Talquetamab (Talvey) plus daratumumab (Darzalex) with or without pomalidomide (Pomalyst) significantly improved survival outcomes over an active regimen for relapsed
Talquetamab (Talvey) plus daratumumab (Darzalex) with or without pomalidomide (Pomalyst) significantly improved survival outcomes over an active regimen for relapsed
U.S. health secretary Robert F. Kennedy Jr. is pursuing federal government access to most Americans’ medical records, in a quest
Fruit-flavored e-cigarettesopens in a new tab or window recently authorized by the FDA were not significantly better at helping smokers
Clinical Takeaway: In patients with hypertension, AI-driven risk stratification using routine EHR data may help identify who should be prioritized
Physician Assistants in Cardiology In the U.K., resident doctors in cardiology reported that it is not uncommon for physician assistants